Pharsight

Children's Advil patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10238640 GLAXOSMITHKLINE Pharmaceutical suspension composition
May, 2024

(7 months from now)

Children'S Advil is owned by Glaxosmithkline.

Children'S Advil contains Ibuprofen.

Children'S Advil has a total of 1 drug patent out of which 0 drug patents have expired.

Children'S Advil was authorised for market use on 27 June, 1996.

Children'S Advil is available in suspension;oral dosage forms.

The generics of Children'S Advil are possible to be released after 25 May, 2024.

Drugs and Companies using IBUPROFEN ingredient

Market Authorisation Date: 27 June, 1996

Treatment: NA

Dosage: SUSPENSION;ORAL

More Information on Dosage

CHILDREN'S ADVIL family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic